Private Equity Fund Investments
Pharma coatings firm Ideal Cures acquired by US-based Colorcon for $250-M
Harleysville, PA (USA)-based Colorcon, Inc. has acquired a majority share in Mumbai-based Ideal Cures, which supplies coatings for tablets and capsules to the pharmaceutical and allied sectors. The deal, reported to be $250 million in size, will mark the exit of Ideal's Private Equity investor TA Associates. Ideal Cures, which will operate as a fully independent entity within Colorcon, complements Colorcon's position in the Indian pharmaceutical market with a strong presence in the domestic generic sector.
From the Venture Intelligence PE-VC Deal Database: TA Associates had invested INR 225 Cr (about USD 34 million) in Mar-17 to acquire a minority stake in Ideal Cures. (Subscribers to the database can login to view the valuation, deal structuring and other transaction details.)
Want to receive such news items in your inbox? Click Here to sign up for a trial.
